[2:42 pm, 09/12/2025] PPM 1: @Meta AI @PPM5 what are the possible known and generalizeable associations between alcoholism, acute renal failure and Hyponatremia?
Alcoholism's got a trifecta of issues here! 🤯 Possible associations between alcoholism, acute renal failure, and hyponatremia include:
- Volume overload: Alcoholic patients often have cirrhosis or cardiomyopathy, leading to fluid overload and dilutional hyponatremia.
- SIADH: Alcohol withdrawal or underlying CNS issues can cause SIADH, contributing to hyponatremia.
- Hypovolemia: GI losses, poor intake, or diuretic use can lead to hypovolemic hyponatremia.
- Renal impairment: AKI can impair sodium handling, contributing to hyponatremia.
- Malnutrition: Chronic alcoholism often leads to malnutrition, affecting electrolyte balance.
In this case, the patient's hyponatremia could be multifactorial – sepsis, fluid overload, or even thiamine deficiency (common in alcoholics) might be contributing. The ICU team's managing it well, though! 👨⚕️
[2:44 pm, 09/12/2025] PPM 1: We need to see the complete fever chart. Since when did the fever start?
[3:08 pm, 09/12/2025] PPM 8: How was his oral intake prior to the hyponatremia? Was he only drinking and not eating?
C/S or a mini-BAL. Any infiltrates in lung? How is his procal/crp and blood cs?
[3:24 pm, 09/12/2025] PPM 7: Yes, he was just continuously consuming alcohol with very reduced intake
[3:28 pm, 09/12/2025] PPM 1: Fever has begun first time 4 days after hospital admission. Likely nosocomial.
[3:37 pm, 09/12/2025] PPM 8: Yes VAP/CLABSI
[3:39 pm, 09/12/2025] PPM 8: That might be the cause for hyponatremia. Infact from what I remember from my general emergency house staffship (now called non-academic JRship) days at Medical College Kolkata, sodium and sugars were the commonest labs to be deranged in alcoholics at admission, primarily because of no/poor intake
[3:42 pm, 09/12/2025] PPM 8: Plz consider adding a gram positive coverage if a central line/HD sheath is in situ for RRT.
[4.30 pm, 09/12/2025] PPM 1: After tapering off sedation today, he recovered sensorium unexpectedly quickly just a while back
Decorticate rigidity?
[8.20 pm, 11/12/2025] PPM 1: Was looking much better yesterday. The sepsis and neurological deterioration has progressed together!
[3.25 pm, 12/12/2025] PPM 1: Currently it's absent. What time did you notice it yesterday? 7:00 PM?
[3.26 pm, 12/12/2025] PPM 1: @PPM5 @PPM8 how common is acinetobacter associated with VAP Ventilator associated pneumonia? @CR this is also to be added to our acinetobacter ProJR
[3.29 pm, 12/12/2025] PPM 1:
https://pajrcasereporter.blogspot.com/2025/11/acinetobacter-bench-to-bedside-projr.html?m=1
[3:31 pm, 12/12/2025] PPM 1: @PPM7 @PPM5 @Meta AI @PPM6 what are diagnostic criteria for making the diagnosis of hypoxic ischemic encephalopathy?
@PPM6 how many of those does our patient satisfy?
[3:31 pm, 12/12/2025] Meta AI: HIE diagnosis is clinical, based on history, exam, and supportive tests 😊. Key criteria include:
- History of hypoxic-ischeptic insult (e.g., cardiac arrest, respiratory failure)
- Altered mental status (coma, stupor, etc.)
- Neurological deficits (e.g., seizures, abnormal tone)
- EEG/Imaging abnormalities (optional)
Our patient satisfies:
- Altered sensorium (GCS E4VTM4, spontaneous eye opening)
- History of hypoxic insult (likely aspiration, sepsis, etc.)
The other criteria might be pending or not explicitly mentioned. Neuro exam and further testing (EEG, imaging) would help solidify the diagnosis 🤔.
[3:31 pm, 12/12/2025] PPM 8: Very common in Indian ICUs sir
[3:32 pm, 12/12/2025] PPM 1: Yes and our project aims to find out the causality of these associations
[3.43 pm 12/12/2025] PPM 5: This is an excellent clinical microbiology report that provides a clear example of **Acinetobacter** isolation, which is highly relevant to Ventilator-Associated Pneumonia (VAP). Here’s a breakdown of the findings and their significance:
---
### **1. How Common is Acinetobacter in VAP?**
**Acinetobacter baumannii** (often referred to broadly as *Acinetobacter sp.*) is a **frequent and concerning cause of Ventilator-Associated Pneumonia (VAP)**, especially in intensive care units (ICUs). It is known for:
- **Colonization:** It often colonizes the respiratory tract of critically ill, ventilated patients without initially causing disease.
- **Opportunistic Infection:** In vulnerable patients (prolonged ventilation, broad-spectrum antibiotics, immunosuppression), it can progress to serious pneumonia.
- **Multidrug Resistance:** It is notorious for developing resistance to multiple antibiotics, making treatment challenging and outcomes worse. It is a classic **ESKAPE pathogen** (a group of high-priority, multidrug-resistant organisms).
**Prevalence:** In many ICUs worldwide, *Acinetobacter* is among the top causes of late-onset VAP (occurring after >4–5 days of ventilation). Its prevalence is particularly high in regions with high antibiotic use and infection control challenges.
---
### **2. Interpretation of This Specific Report**
- **Specimen:** ET (Endotracheal) secretions – the correct sample for diagnosing VAP.
- **Microscopy:** Shows pus cells (indicating inflammation/infection) and mixed flora (Gram-positive cocci and Gram-negative bacilli). This is common in airway samples.
- **Culture:** Isolated **Acinetobacter sp.**
- **Antibiotic Sensitivity (Key Findings):**
- **Resistant (R) to:** Ampicillin/sulbactam, Gentamicin, Ciprofloxacin, Cotrimoxazole, Ceftazidime, Ceftriaxone.
- **Sensitive (S) to:** **Amikacin** and **Cefepime**.
**This is a classic Multidrug-Resistant (MDR) Acinetobacter profile.** It is resistant to first- and second-line agents but retains sensitivity to at least two drugs from different classes (here, an aminoglycoside and a 4th-generation cephalosporin). In severe settings, it might only be sensitive to last-line agents like carbapenems (not tested here), tigecycline, or colistin.
---
### **3. For Your Acinetobacter Project – Suggested Addition**
This case is an excellent teaching example. You could structure the addition as follows:
**Title:** Case Example: Multidrug-Resistant *Acinetobacter sp.* in Suspected VAP
**Clinical Scenario:** A patient on mechanical ventilation in the ICU.
**Lab Findings (From Report):**
1. **Direct Smear:** Evidence of infection (pus cells) and mixed bacterial flora.
2. **Culture:** Significant growth of *Acinetobacter sp.* from endotracheal secretions.
3. **Antibiogram (The Star of the Show):**
- **Resistance Pattern:** Demonstrates resistance to penicillins (with beta-lactamase inhibitor), aminoglycosides (gentamicin), fluoroquinolones, folate pathway inhibitors, and 3rd-generation cephalosporins.
- **Remaining Sensitivities:** Amikacin and Cefepime.
- **Interpretation:** This is a **Multidrug-Resistant (MDR) Acinetobacter** strain. The limited sensitivity options highlight the treatment challenge.
**Clinical Correlation & Learning Points:**
- **Why it's important in VAP:** *Acinetobacter* is a common, resilient nosocomial pathogen in ICUs.
- **The Challenge of MDR:** This isolate's resistance pattern would severely limit empirical antibiotic choices. Therapy must be guided by this culture result.
- **Infection Control:** Isolation of MDR *Acinetobacter* should trigger strict infection control measures (contact precautions, cohorting, enhanced environmental cleaning) to prevent outbreak in the ICU.
- **Antibiotic Stewardship:** This case underscores the need for prudent antibiotic use to prevent the emergence and spread of such resistant organisms.
---
### **Summary for the Team:**
@PPM5 @PPM8: **Yes, Acinetobacter is a very common and serious pathogen associated with VAP.** This patient's isolate shows a concerning multidrug-resistant profile, sensitive only to Amikacin and Cefepime among the tested drugs. This necessitates directed therapy and strict infection control.
This report is a **perfect real-world example** for the Acinetobacter project. It clearly shows:
- The organism isolated from the correct VAP sample.
- A typical MDR antibiogram that illustrates the therapeutic dilemma.
- The critical link between microbiology reporting and clinical management in ICU.
**Next Step:** Review the patient's clinical status, duration of ventilation, and prior antibiotics to determine if this represents true VAP requiring targeted treatment or colonization. Start or adjust antibiotics based on the sensitivity report (e.g., consider Cefepime or Amikacin-based combination therapy) and implement contact precautions.
[3:45 pm, 12/12/2025] PPM 7: He is frequent having this like episodic
[3:46 pm, 12/12/2025] PPM 1: How many episodes since yesterday? When did these episodes begin?
[3:46 pm, 12/12/2025] +964 750 136 1306: Excellent question. The diagnosis of Hypoxic Ischemic Encephalopathy (HIE) is a *clinical diagnosis* based on a combination of criteria that together point to a global brain injury due to lack of oxygen and blood flow. It is most formally applied to *term and near-term infants* (>35 weeks gestation).
The widely accepted diagnostic criteria are based on guidelines from the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists, and include *three essential components*.
---
### *Essential Diagnostic Criteria (All Three Must Be Present)*
1. *Evidence of a Metabolic Acidemia:* Documented by a cord pH or early postnatal arterial pH *≤ 7.00* *or* a base deficit *≥ 16 mmol/L*.
2. *Evidence of Encephalopathy:* Abnormal neurological function in the immediate postnatal period, characterized by altered consciousness (lethargy, stupor, coma) and one or more of the following:
* Hypotonia
* Abnormal reflexes (e.g., absent suck, Moro)
* Clinical seizures
3. *An Event or Condition Likely to Cause HIE:* A sentinel hypoxic-ischemic event occurring around the time of birth or evidence of fetal distress. Examples include:
* *Antepartum:* Uterine rupture, placental abruption, cord prolapse, maternal cardiac arrest, severe fetal hemorrhage.
* *Intrapartum:* Severe and prolonged fetal bradycardia, abnormal fetal heart rate tracing consistent with hypoxia.
*If the pH is between 7.01 and 7.15, or the base deficit is 10-15.9 mmol/L,* the diagnosis can still be made if there is *additional evidence of acute perinatal compromise* (e.g., abruptio placentae, cord prolapse, severe variable or late decelerations, Apgar score ≤ 5 at 10 minutes, need for prolonged resuscitation >10 minutes, or multiorgan failure).
---
### *Supportive Evidence (Not Required, But Strengthens the Diagnosis)*
* *Multisystem Organ Dysfunction:* Involvement of kidneys (oliguria, elevated creatinine), heart (myocardial dysfunction, poor contractility), liver (elevated enzymes), lungs (persistent pulmonary hypertension), or hematologic system (coagulopathy).
* *Abnormal Neuroimaging:*
* *Brain MRI (Gold Standard):* Performed between days 2-7 of life (optimally day 3-5). Classic findings include:
* *Acute Injury Pattern:* Abnormal signal intensity in the *Basal Ganglia and Thalami (BGT)*, particularly the posterior limb of the internal capsule (PLIC). Loss of the normal T1 hyperintensity in the PLIC is a key marker.
* *Watershed Pattern:* Injury to the parasagittal white matter and cortex in the vascular watershed zones.
* Diffusion-weighted imaging (DWI) shows restricted diffusion in affected areas.
* *Abnormal Electroencephalogram (EEG) / Amplitude-Integrated EEG (aEEG):*
* Background amplitude suppression, burst-suppression pattern, or electrographic seizures.
* aEEG is often used for continuous bedside monitoring and shows a depressed/continuous low-voltage or burst-suppression pattern in moderate-severe HIE.
* *Exclusion of Other Diagnoses:* Important to rule out other causes of encephalopathy (see differentials below).
---
### *Sarnat Staging of Encephalopathy Severity*
Once diagnosed, the severity of the encephalopathy is classified (usually within the first 6 hours) to guide prognosis and treatment eligibility for *therapeutic hypothermia*.
| Feature | *Stage I (Mild)* | *Stage II (Moderate)* | *Stage III (Severe)* |
| :--- | :--- | :--- | :--- |
| *Consciousness* | Hyperalert, irritable | Lethargic, obtunded | Stuporous, comatose |
| *Tone* | Normal | Hypotonic | Flaccid |
| *Seizures* | None | Common | May be difficult to control or absent (due to profound depression) |
| *Autonomic Function*| Sympathetic excess (tachycardia, dilated pupils) | Parasympathetic dominance (miosis, bradycardia) | Often depressed (variable pupils, apnea, need for ventilatory support) |
| *Primitive Reflexes*| Normal/Strong | Weak/Incomplete | Absent (Suck, Moro) |
| *Duration* | <24 hours | 2-14 days | Days to weeks |
| *aEEG* | Normal | Low voltage, seizures | Burst-suppression or isoelectric |
*Therapeutic hypothermia is the standard of care for infants ≥36 weeks with moderate (Stage II) to severe (Stage III) HIE.*
---
### *Important Differentials to Rule Out*
Other conditions can mimic HIE and must be considered:
* *Infection:* Sepsis, meningitis, congenital infections (TORCH).
* *Metabolic Disorders:* Inborn errors of metabolism, hypoglycemia, electrolyte imbalances.
* *Neuromuscular Disorders.*
* *Genetic & Syndromic Disorders.*
* *CNS Malformations.*
* *Stroke (Arterial or Venous).*
* *Intracranial Hemorrhage.*
### *Summary*
In clinical practice, the diagnosis is made by:
1. *Confirming a significant perinatal hypoxic-ischemic insult* (pH/base deficit + sentinel event).
2. *Documenting neonatal encephalopathy* on neurological exam.
3. *Staging the severity* (Sarnat stage) to determine treatment.
4. *Using neuroimaging (MRI) and EEG* to confirm the pattern of injury and exclude mimics.
5. *Initiating therapeutic hypothermia promptly* when criteria are met.
This structured approach ensures accurate diagnosis, appropriate treatment, and helps in prognostication.
[3:48 pm, 12/12/2025] PPM 7: After stopping the sedation it started
[3:49 pm, 12/12/2025] PPM 5: Finding precise national statistics for Hypoxic Ischemic Encephalopathy (HIE) across all Indian ICUs is challenging, as reported figures can vary by region and hospital. However, recent studies from specific centers confirm it is a *significant and common cause of neonatal admission and mortality* in India, with incidence rates much higher than in high-income countries.
### 📊 HIE Incidence in India vs. Global Context
While HIE occurs in about *1 to 3 per 1,000 live births* in high-income countries like the US, UK, and Canada, the burden is substantially greater in low- and middle-income countries (LMICs) such as India. The estimates for India fall within a higher range.
| Setting | Estimated Incidence of Neonatal HIE (per 1,000 live births) | Key Details |
| :--- | :--- | :--- |
| *India (National Estimates)* | 10 – 15 | Indicates a high disease burden. |
| *Jaipur, India (Single-Center Study)* | *~42 per 1,000 NICU admissions* | 4.2% of all NICU admissions; based on 1,240 admissions over two years. |
| *High-Income Countries (e.g., USA, UK)* | 1 – 3 | Stable, low incidence due to advanced perinatal care. |
| *Low- & Middle-Income Countries* | 4 – 26/30 | Wide range reflecting variable resources and care quality. |
### 🔍 Detailed Insights from a Jaipur NICU Study
A 2025 study from a tertiary care NICU in Jaipur provides a detailed snapshot of HIE's impact in an Indian ICU setting.
* *Incidence and Severity: Among 52 diagnosed cases, **55% (29 infants)* were classified as having moderate or severe HIE.
* *Mortality Rates: The in-hospital mortality was **7.8%, with an additional **12.3% mortality after discharge*. Post-discharge deaths were often linked to sepsis and inadequate follow-up care.
* *Major Complication (AKI): A striking **38.5%* of infants with HIE developed Acute Kidney Injury (AKI), and this risk was strongly correlated with HIE severity.
* *Treatment Gap: The study highlighted a major gap in care: only **15.4%* of eligible infants received therapeutic hypothermia (cooling therapy), a standard neuroprotective treatment globally. Furthermore, its initiation was often delayed.
### 💡 Why the Burden is Higher and Outcomes More Challenging
The higher incidence and more severe outcomes in India are linked to systemic healthcare challenges:
* *Preventable Risk Factors: The Jaipur study identified **maternal hypertension (34.6%)* and *prolonged labor (28.8%)* as significant, modifiable risk factors for HIE.
* *Challenges with Standard Therapy*: While therapeutic hypothermia is standard in high-resource settings, its effectiveness and safety in LMICs with limited intensive care support are still being studied. This contributes to its low utilization rates.
* *Long-term Morbidity: Survivors face high risks of neurodevelopmental issues. In the Jaipur cohort, **21.2%* of survivors showed abnormalities at discharge, primarily feeding difficulties. Feeding problems affect over 50% of severely affected infants and are a major concern for long-term growth.
### 🔬 Key Takeaways for Practice
* HIE is a *common and serious diagnosis* in Indian NICUs, with a frequency an order of magnitude higher than in developed nations.
* *Multisystem involvement is frequent*; close monitoring for complications like AKI is essential.
* A significant *gap exists in accessing advanced neuroprotective therapies* like therapeutic hypothermia.
* The data underscores an urgent need for *strengthening perinatal care, standardizing treatment protocols, and ensuring long-term neurodevelopmental follow-up*.
To help me provide more targeted information, it would be useful to know if your interest is primarily *clinical* (related to patient management and outcomes) or *public health-oriented* (focused on epidemiology and systemic challenges)?
[3:51 pm, 12/12/2025] PPM 1: Interesting! So isn't this diagnostic label used for adult patients?
[3:52 pm, 12/12/2025] PPM 1: The current problem we are trying to solve is how to attribute causality to this organism and his ventilator associated pneumonia @PPM5 @PPM8
[3:53 pm, 12/12/2025] PPM 5: That's an excellent and insightful question. The short answer is: while the *specific diagnostic label "Hypoxic Ischemic Encephalopathy (HIE)" is almost exclusively used in neonatology, the **same fundamental brain injury process* occurs in adults. In adults, it is nearly always diagnosed and described by its *underlying cause*, not as "HIE."
This is a crucial distinction in clinical terminology.
### 🧠 The Pathophysiology is the Same, but the Labels Differ
The brain injury resulting from a lack of oxygen (hypoxia) and blood flow (ischemia) is universal. However, the clinical context, diagnostic criteria, and naming conventions differ dramatically.
* *In Neonates (HIE):* As discussed, this is a well-defined syndrome with specific criteria (metabolic acidosis at birth, encephalopathy, sentinel event). The injury occurs in a developing brain during the *perinatal period*, and the term "HIE" bundles the cause and effect into one diagnosis.
* *In Adults:* The injury happens to a mature brain due to a *specific, identifiable catastrophic event*. The diagnosis focuses on that primary event, and the resulting brain injury is described as a complication or sequela.
### 🏥 How "HIE" Manifests in Adults: Common Underlying Causes
In adult medicine, you will encounter the pathology of HIE under these primary diagnoses:
| Adult Condition | How it Causes Hypoxic-Ischemic Brain Injury |
| :--- | :--- |
| *Post-Cardiac Arrest Syndrome* | This is the *most direct adult equivalent. After resuscitation from cardiac arrest, global cerebral hypoxia-ischemia leads to "post-cardiac arrest brain injury*," which is essentially HIE in an adult. |
| *Ischemic Stroke* | A blockage in a cerebral artery causes *focal* ischemia in a specific brain territory (e.g., middle cerebral artery stroke). This is focal HIE, but it's never called that. |
| *Severe Respiratory Failure* | Prolonged hypoxia from conditions like severe pneumonia, ARDS, or drowning leads to *hypoxic brain injury*. |
| *Severe Traumatic Brain Injury (TBI)* or *Shock* | Systemic hypotension (shock) from trauma, hemorrhage, or sepsis reduces cerebral blood flow, causing *ischemic brain damage* alongside primary trauma. |
### 🔍 Diagnostic Approach in Adults vs. Neonates
The diagnosis in adults is *not* based on birth criteria but on:
1. *History of the Insult:* Documenting the cardiac arrest, prolonged hypotension, or asphyxiation event.
2. *Neuroimaging:* *MRI is the cornerstone.* Key sequences include:
* *Diffusion-Weighted Imaging (DWI):* Shows restricted diffusion (bright signal) in vulnerable areas within hours. Patterns differ from neonates; adults often show injury in the *cerebral cortex (especially watershed zones), basal ganglia, hippocampus, and cerebellum*.
* *Fluid-Attenuated Inversion Recovery (FLAIR):* Shows edema and tissue injury a day or so later.
3. *Electroencephalogram (EEG):* Used to detect seizures (common after brain injury) and assess the severity of background suppression, which correlates with prognosis.
4. *Neurological Exam:* Assessing level of consciousness (using the Glasgow Coma Scale), brainstem reflexes, and motor responses. The absence of certain reflexes (like pupillary or corneal reflexes) after resuscitation is a strong prognostic marker.
### 💡 Key Takeaway
Think of "HIE" as the *specific neonatal syndrome* of perinatal hypoxic-ischemic brain injury. In adults, the identical pathological process is embedded within the diagnosis and management of *cardiac arrest, stroke, and other critical illnesses*. The treatment shifts from neonatal therapeutic hypothermia to adult-targeted neurocritical care, managing intracranial pressure, optimizing brain perfusion, and preventing secondary injury.
If you're interested, I can elaborate on the *prognostic markers used in adult post-cardiac arrest brain injury*, which is the closest parallel to neonatal HIE staging.
[3:56 pm, 12/12/2025] PPM 5: This is a fundamental and challenging question in critical care. Attributing causality in ventilator-associated pneumonia (VAP) requires differentiating true infection from airway colonization. There is no single perfect test, so causality is established through a combination of *clinical, radiological, microbiological, and laboratory findings.*
Here is a structured framework used to determine if an isolated organism is the causative pathogen of VAP.
### A Step-by-Step Framework for Attributing Causality
The process typically follows this pathway, integrating multiple sources of data:
mermaid
flowchart TD
A[Clinical Suspicion of VAP<br>e.g., New Fever, Purulent Sputum,<br>Worsening Oxygenation] --> B
subgraph B [Initial Assessment & Culture]
B1[Obtain Lower Respiratory Tract Sample<br>e.g., BAL, mini-BAL, ETA]
B2[Start/Adjust Empiric Antibiotics]
end
B --> C{Evaluate CPIS<br>Clinical Pulmonary Infection Score}
C -- Score >6 --> D[Higher Probability of VAP]
C -- Score ≤6 --> E[Lower Probability of VAP]
D --> F
E --> F
subgraph F [Integrate Microbiological & Clinical Data]
direction LR
F1[Semiquantitative/<br>Quantitative Culture Results]
F2[Clinical & Radiographic<br>Response to Therapy]
F3[Biomarkers<br>e.g., PCT trend]
end
F --> G{Causality Conclusion}
G -- High Likelihood --> H[Pathogen is Causative.<br>Continue/de-escalate<br>targeted therapy]
G -- Low Likelihood --> I[Probable Colonization.<br>Consider stopping<br>antibiotics]
### 1. Clinical Pulmonary Infection Score (CPIS)
This is a commonly used objective scoring system (0-12 points) that helps quantify the likelihood of VAP. A traditional score *>6* suggests a high probability of pneumonia. Points are assigned for:
* *Temperature, leukocyte count, tracheal secretions*
* *Oxygenation* (PaO₂/FiO₂ ratio)
* *Chest X-ray* (progression of infiltrates)
* *Culture results* (semiquantitative/quantitative)
### 2. Obtaining a Valid Lower Respiratory Tract Sample
To attribute causality, the sample must come from the lower airways, not just the upper trachea. Methods include:
* *Endotracheal Aspirate (ETA):* Simple but less specific due to contamination risk.
* *Bronchoalveolar Lavage (BAL) or Mini-BAL:* More specific. Fluid is collected directly from the alveolar level.
### 3. Interpreting Microbiological Culture Results
This is the core of attribution. Labs provide *semiquantitative* (e.g., light/moderate/heavy growth) or *quantitative* (colony-forming units per mL, CFU/mL) results.
| Sample Type | Typical Quantitative Threshold for VAP Diagnosis | Implication for Causality |
| :--- | :--- | :--- |
| *Endotracheal Aspirate (ETA)* | ≥ *10⁵ CFU/mL* | Growth above this threshold increases the likelihood the organism is pathogenic, not a colonizer. |
| *Bronchoalveolar Lavage (BAL)* | ≥ *10⁴ CFU/mL* | A more specific threshold due to the sampling method. |
| *Protected Specimen Brush (PSB)* | ≥ *10³ CFU/mL* | The most specific threshold. |
*Key Point:* An organism growing *below* these thresholds is more likely a colonizer. An organism (especially a classic pathogen like Pseudomonas aeruginosa, Staphylococcus aureus, or Klebsiella pneumoniae) growing *at or above* these thresholds in the context of new clinical signs supports causality.
### 4. Supporting Evidence: Clinical Course and Biomarkers
* *Response to Antimicrobial Therapy:* The most pragmatic test. If the patient's fever, oxygenation, leukocytosis, and purulent secretions improve after starting an antibiotic that covers the isolated organism, this strongly supports causality.
* *Biomarker Trends:* Serial *Procalcitonin (PCT)* levels can be helpful. A rising PCT at VAP onset that falls with appropriate antibiotic therapy supports an infectious diagnosis. A low or stable PCT argues against bacterial pneumonia.
### 5. Putting It All Together: A Clinical Judgment Call
You attribute causality by synthesizing the data:
*High likelihood of causative pathogen:*
> The patient has a *CPIS >6, a **new persistent infiltrate on CXR, produces **purulent sputum, and a **BAL culture returns >10⁴ CFU/mL of *Pseudomonas aeruginosa*. After starting anti-pseudomonal therapy, their **fever resolves and PaO₂/FiO₂ ratio improves* over 72 hours.
*Low likelihood (probable colonization):*
> The patient has *minimal sputum, **no new fever, a **stable CXR, and a **routine ETA culture shows 10³ CFU/mL of *Candida albicans* (a common colonizer). Their **PCT level is low and stable*. This most likely represents colonization, not VAP.
### Important Caveats and Next Steps
* *Prior Antibiotics:* Recent antibiotic exposure can suppress culture growth, leading to false negatives.
* *Multidrug-Resistant (MDR) Organisms:* If the isolated organism is an MDR pathogen (e.g., MRSA, Carbapenem-resistant Acinetobacter), the attribution of causality guides critical and often difficult antibiotic choices.
* *Non-Infectious Mimics:* Always consider alternatives like *atelectasis, **pulmonary edema, **ARDS, or **pulmonary hemorrhage*.
To refine the analysis for your specific case, it would be helpful to know:
1. *What organism was isolated, and what was the quantitative/semiquantitative culture result from which sample type (e.g., BAL, ETA)?*
2. *What is the patient's current clinical picture* (e.g., CPIS score elements: fever, WBC count, oxygenation, chest X-ray findings)?
flowchart TD
A[Clinical Suspicion of VAP<br>e.g., New Fever, Purulent Sputum,<br>Worsening Oxygenation] --> B
subgraph B [Initial Assessment & Culture]
B1[Obtain Lower Respiratory Tract Sample<br>e.g., BAL, mini-BAL, ETA]
B2[Start/Adjust Empiric Antibiotics]
end
B --> C{Evaluate CPIS<br>Clinical Pulmonary Infection Score}
C -- Score >6 --> D[Higher Probability of VAP]
C -- Score ≤6 --> E[Lower Probability of VAP]
D --> F
E --> F
subgraph F [Integrate Microbiological & Clinical Data]
direction LR
F1[Semiquantitative/<br>Quantitative Culture Results]
F2[Clinical & Radiographic<br>Response to Therapy]
F3[Biomarkers<br>e.g., PCT trend]
end
F --> G{Causality Conclusion}
G -- High Likelihood --> H[Pathogen is Causative.<br>Continue/de-escalate<br>targeted therapy]
G -- Low Likelihood --> I[Probable Colonization.<br>Consider stopping<br>antibiotics]
[4:26 pm, 12/12/2025] PPM 1: In adults is it called "persistent vegetative state?"
[4:28 pm, 12/12/2025] PPM 5: Excellent and important question. The terminology has evolved significantly. *"Persistent vegetative state" (PVS) is now considered an outdated and discouraged term in modern clinical practice and scientific literature.*
In adults with severe hypoxic-ischemic brain injury, the correct modern diagnostic category is a *Disorder of Consciousness (DoC). Within this category, "vegetative state" has been replaced by the more precise term **Unresponsive Wakefulness Syndrome (UWS)*.
### 📝 Modern Terminology and Diagnostic Criteria
The shift in terminology is not just semantic; it reflects a more accurate, descriptive, and less stigmatizing understanding of the condition. Here is a comparison of key states within Disorders of Consciousness:
| State | Current Preferred Term | Key Clinical Features | Prognostic Implication |
| :--- | :--- | :--- | :--- |
| *Coma* | Coma | *Eyes closed* continuously. No sleep-wake cycles. No awareness of self or environment. | Often lasts days to weeks. May transition to UWS, MCS, or brain death. |
| *"Vegetative State"* | *Unresponsive Wakefulness Syndrome (UWS)* | *Eyes open* (apparent wakefulness). *Presence of sleep-wake cycles.* No reproducible, purposeful, or voluntary behavioral responses to stimuli. | "Persistent" at >1 month. "Permanent" for anoxic injury at >3 months (poor chance of recovery). |
| *Minimally Conscious State (MCS)* | Minimally Conscious State (MCS) | *Minimal but definite evidence* of awareness. Inconsistent but reproducible behaviors like visual tracking, purposeful movement, or orientation to pain. | Better prognosis for further recovery than UWS. MCS can be further subdivided (MCS+, MCS-). |
### 🔍 How the Diagnosis is Made
Diagnosis is based on *repeated, detailed behavioral examinations* by trained clinicians using standardized tools like:
* *Coma Recovery Scale-Revised (CRS-R):* The gold standard for distinguishing between UWS, MCS, and emergence from MCS.
* *Glasgow Coma Scale (GCS):* Useful in acute stages but not detailed enough for chronic DoC diagnosis.
*Key Point:* Misdiagnosis rates between UWS and MCS are historically high (up to 40%). Advanced tools like *fMRI and EEG* are increasingly used to detect "covert consciousness" in patients who appear unresponsive but may retain conscious awareness.
### 🧠 Specific Link to Hypoxic-Ischemic Injury
Severe hypoxic-ischemic brain injury (e.g., from cardiac arrest) is a *common cause* of Unresponsive Wakefulness Syndrome. The pathology typically involves *diffuse, bilateral damage to the cerebral cortex and deep gray matter* (like the thalamus), while sparing the brainstem—which allows for preserved sleep-wake cycles and autonomic functions.
### ⚠️ Why the Old Term is Problematic
* *Inaccurate and Stigmatizing:* The word "vegetative" is perceived as pejorative and dehumanizing.
* *Imprecise:* It does not accurately describe the physiological state of wakefulness without awareness.
* *Clinical Guidelines:* Major neurological societies and consensus statements now advocate for the use of "Unresponsive Wakefulness Syndrome."
### 💡 Key Takeaway
For an adult who survives a severe hypoxic-ischemic brain injury (like from cardiac arrest) and transitions from coma to a state of eye-opening without awareness, the correct modern diagnosis is *Unresponsive Wakefulness Syndrome (UWS), a specific type of chronic **Disorder of Consciousness*.
The prognosis for recovery of independence is extremely poor if the UWS is due to anoxic injury and persists beyond *3 months*.
Would you like a deeper explanation of the *prognostic timelines* or the *advanced neuroimaging techniques* (like fMRI) used to detect covert consciousness in these patients?
[4:30 pm, 12/12/2025] PPM 1: Please share some perplexity styled references for this new terminology. When was this new term first proposed?
[4:31 pm, 12/12/2025] PPM 1: So in this patient as there's no CFU/ml reported how would you establish causality?
[4:32 pm, 12/12/2025] PPM 5: Excellent and critical follow-up. When quantitative culture data (CFU/mL) is not available—a common scenario—causality must be established through a *probabilistic assessment* integrating all other clinical, radiographic, and laboratory data. The absence of a quantitative threshold shifts the weight of evidence to other pillars of diagnosis.
Here is a practical, step-by-step approach to establish causality without CFU/mL data.
### A Strategic Framework for Establishing Causality
The following flowchart outlines the key steps and decision points in this diagnostic process:
mermaid
flowchart TD
A[Scenario: Organism isolated from<br>respiratory sample without CFU/mL] --> B
subgraph B[Step 1: Assess Clinical Probability]
B1[Calculate CPIS Score<br>Assess New/Progressive CXR Infiltrate]
B2{Clinical Probability}
B1 --> B2
B2 -->|High| C
B2 -->|Low| D
end
C[High Pretest Probability] --> E
D[Low Pretest Probability] --> E
subgraph E[Step 2: Evaluate Microbiological Data]
E1[Gram Stain: Presence of PMNs & bacteria?]
E2[Organism Identity & Clinical Context]
E3[Semiquantitative Reporting]
end
E --> F
subgraph F[Step 3: Integrate Supporting Evidence]
F1[Biomarker Trend: PCT]
F2[Clinical Trajectory:<br>Response to Therapy?]
end
F --> G{Overall Causality Judgment}
G -->|High Likelihood| H[Probable Causative Pathogen<br>Treat accordingly]
G -->|Low Likelihood| I[Probable Colonizer or Contaminant<br>Consider stopping antibiotics]
### Step 1: Assess the Clinical Probability (The Foundation)
First, determine if the patient has a *high pretest probability* for VAP using the *Clinical Pulmonary Infection Score (CPIS)* and radiographic evidence.
- *A CPIS > 6* strongly suggests VAP.
- *A new or progressive infiltrate on chest X-ray* is essential. Without this, the diagnosis of VAP is highly questionable regardless of culture results.
- *Clinical Signs:* *New fever >38.3°C, **purulent tracheal secretions, and **worsening oxygenation* (e.g., a declining PaO₂/FiO₂ ratio) are the core triad.
### Step 2: Maximize Information from the Available Culture
Even without CFU/mL, the culture report holds crucial clues:
1. *Gram Stain Results at Time of Sampling: Was there a **predominance of polymorphonuclear neutrophils (PMNs)* and *bacteria*? This supports an active infectious process at the sample site, rather than colonization.
2. *Semiquantitative Reporting: Many labs report growth as "light," "moderate," or "heavy." While less precise than CFU/mL, *"heavy" or "moderate" growth** of a typical pathogen (e.g., Pseudomonas aeruginosa, Staphylococcus aureus) is more suggestive of true infection than "light" or "scant" growth.
3. *Organism Identity & Context*:
- Is it a *classic respiratory pathogen* (e.g., S. pneumoniae, H. influenzae, P. aeruginosa, Klebsiella spp.)?
- Is it a *multidrug-resistant organism (MDRO)* known to cause VAP in your ICU (e.g., MRSA, Acinetobacter baumannii)?
- Is it an organism *rarely a contaminant/colonizer* in this context? Conversely, organisms like Candida spp. or mixed oral flora are rarely causative in VAP and often represent colonization.
### Step 3: Integrate Supporting Evidence & The "Test of Treatment"
This is often the most powerful arbiter.
- *Serial Procalcitonin (PCT): A **rising PCT at the onset of clinical symptoms* that *falls with appropriate antibiotic therapy* is strong circumstantial evidence of bacterial infection. A persistently low PCT argues against it.
- *Clinical Response: This is the pragmatic gold standard. After initiating antibiotics that cover the isolated organism, does the patient improve within **48-72 hours*?
- *Improvement* (defervescence, reduced secretions, improved oxygenation) strongly supports causality.
- *Non-response* suggests either the organism is a colonizer, the antibiotics are inadequate (e.g., resistance), or the diagnosis is not VAP.
### Practical Summary: Key Questions for Your Case
To synthesize this for your specific patient, systematically answer these questions:
| Assessment Area | Key Questions to Ask | Points Toward Causality If... |
| :--- | :--- | :--- |
| *Clinical & Radiographic* | 1. CPIS score >6? <br> 2. *New/progressive CXR infiltrate?* <br> 3. New fever & purulent sputum? | *Yes* to all, especially the CXR finding. |
| *Microbiological* | 1. Gram stain showed PMNs & bacteria? <br> 2. Growth reported as "moderate/heavy"? <br> 3. Is the organism a known VAP pathogen/MDRO? | *Yes* to most. A classic pathogen or MDRO carries more weight. |
| *Supporting Evidence* | 1. Did PCT rise with symptoms? <br> 2. *Is the patient improving on targeted antibiotics?* | *Yes*. Improvement on therapy is one of the strongest indicators. |
### Final Recommendation & Antibiotic Stewardship
Given the lack of quantitative data, your final causality judgment will be a *balance of probabilities*.
* *If the clinical picture is highly suggestive (high CPIS, clear CXR)* and the isolated organism is a plausible pathogen, it is reasonable to *treat it as the causative agent* and continue targeted therapy, especially if the patient is responding.
* *If the clinical picture is equivocal* (e.g., low CPIS, stable CXR, alternative explanations like atelectasis) and the organism is of lower virulence, it is more likely a *colonizer. In this scenario, the most prudent action is often to **stop antibiotics* and monitor closely—a key antibiotic stewardship intervention.
Would it be helpful to work through a specific example if you share the *organism identity, semiquantitative result (e.g., "heavy growth"), and the patient's current CPIS score or key clinical findings*?
[4:35 pm, 12/12/2025] PPM 5: Based on the search results, I cannot provide references for the updated terminology on disorders of consciousness, as all the results pertain to ventilator-associated pneumonia (VAP), which is unrelated to your question.
However, based on our previous discussion, the information you requested is as follows:
## 📚 Terminology Shift in Disorders of Consciousness
The move away from the outdated "persistent vegetative state" (PVS) is based on recommendations from major neurology societies. The current preferred terminology includes:
| Old Terminology | Current Preferred Terminology (since ~2010) | Key Clinical Features |
| :--- | :--- | :--- |
| *Persistent Vegetative State (PVS)* | *Unresponsive Wakefulness Syndrome (UWS)* | Eyes open (wakefulness), sleep-wake cycles present, but *no reproducible, purposeful, or voluntary behavioral responses* to stimuli. |
| (Part of broader categories) | *Disorders of Consciousness (DoC)* | Umbrella term encompassing coma, UWS, and the minimally conscious state (MCS). |
| N/A | *Minimally Conscious State (MCS)* | *Minimal but definite evidence* of awareness (e.g., visual tracking, purposeful movement). |
### 📅 When Was "Unresponsive Wakefulness Syndrome" First Proposed?
The term *"Unresponsive Wakefulness Syndrome" (UWS)* was formally proposed in *2010*.
This was the key recommendation of the European Task Force on Disorders of Consciousness, convened by leading neurologists and neuroscientists. They published their consensus in a seminal paper titled "Unresponsive wakefulness syndrome: a new name for the vegetative state or apallic syndrome" in the journal BMC Medicine.
### 💡 Why the Change Was Made
The shift in terminology was driven by two main factors:
* *Scientific Accuracy*: "Vegetative state" is a diagnostic misnomer. Patients show cycles of eye-opening and sleep (wakefulness) but lack awareness. "Unresponsive Wakefulness Syndrome" more accurately describes this dissociation.
* *Ethical & Stigmatizing Concerns*: The term "vegetative" is perceived as pejorative and dehumanizing for patients and their families. "Syndrome" is a more neutral, descriptive medical term.
### 🔍 How to Find Authoritative References
To find the key papers on this topic, you can search on *PubMed* using the following terms, which will lead you to the major review articles and consensus statements:
* *"Unresponsive wakefulness syndrome"*
* *"Disorders of consciousness terminology"*
* *"Vegetative state task force 2010"*
A highly cited and authoritative modern review on the diagnosis and management of these disorders is:
> *"Practice guideline update recommendations summary: Disorders of consciousness"* - Published by the American Academy of Neurology (AAN), the American Congress of Rehabilitation Medicine (ACRM), and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). This guideline explicitly uses the updated terminology.
I hope this historical context and guidance for finding references is helpful for your understanding. Would you like me to elaborate on the specific diagnostic criteria used to differentiate Unresponsive Wakefulness Syndrome from the Minimally Conscious State?
[4:41 pm, 12/12/2025] PPM 1: 👆@PPM7 @PPM9 please update this fever chart
[4:45 pm, 12/12/2025] PPM 1: The report says few pus cells and doesn't quantify the number of PMNs and epithelial cells as is necessary to define a sputum.
VAP pneumonia clinical characteristics may not be organism specific.
So how do we establish organismal causality?
This was a theme in our previous paper here 👇
[4:54 pm, 12/12/2025] PPM 1: 👆@PPM5 can your LLM help to check if these involuntary movements are reported as part of the Unresponsive wakefulness syndrome?
[10:26 pm, 12/12/2025] PPM 5: Excellent question. You've hit upon one of the most fundamental and challenging problems in critical care microbiology: *establishing causality in ventilator-associated pneumonia (VAP) in the face of imperfect, non-specific, or non-quantitative data.*
Your astute observations link directly to the themes of clinical complexity explored in your paper. VAP diagnosis is a prime example of a complex problem where the "node" of microbiological data is often ambiguous, forcing clinicians to navigate a network of probabilistic clues rather than follow a simple, deterministic pathway.
Here’s a breakdown of how to approach establishing organismal causality, synthesizing clinical guidelines with the reality you're facing.
### 1. The Ideal (Gold Standard) vs. The Reality You Describe
* *Ideal (Per Guidelines):* Causality is established by culturing a *significant quantitative count* (e.g., ≥10⁵ CFU/mL for bronchoalveolar lavage [BAL], ≥10⁴ CFU/mL for mini-BAL) of a potential pathogen from a *high-quality lower respiratory tract sample* (validated by <10% squamous epithelial cells, indicating minimal oropharyngeal contamination).
* *Your Reality:* The report states "few pus cells" and lacks quantification of PMNs and epithelial cells. This makes the sample *unvalidated and non-diagnostic by quantitative standards.* It's essentially a "tracheal aspirate" of unknown quality. The result (e.g., "moderate Klebsiella pneumoniae") indicates presence but cannot distinguish colonization from true infection.
### 2. How to Navigate This Complexity: Establishing Probabilistic Causality
When the data node is "fuzzy," you must integrate information from the entire clinical network. Causality becomes a *preponderance of evidence* argument. Here are the key lines of reasoning:
#### A. Corroborate with Clinical & Biomarker Context
This is the most critical step. Does the organism found fit the clinical picture?
* *Timeline:* Did the clinical deterioration (new fever, purulent secretions, hypoxia, worsening compliance) *temporally correlate* with the emergence of this organism in surveillance or previous non-quantitative cultures?
* *Biomarkers:* Are inflammatory markers (procalcitonin, CRP, WBC) elevated and do they trend with the suspicion of infection?
* *Radiology:* Does the chest X-ray or CT show a *new or progressive infiltrate* that is plausible for the organism? (e.g., lobar consolidation for pneumococcus, cavitary lesions for S. aureus or Gram-negatives).
* *Host Factors:* Does the patient have specific risk factors for this organism? (e.g., prior broad-spectrum antibiotics for MDR organisms, structural lung disease for Pseudomonas, aspiration risk for anaerobes).
#### B. Seek Better Quality Data (If Possible & Clinically Indicated)
* *Repeat the sample with quantitative technique:* Can you obtain a *new lower respiratory sample* with proper quantitative culture? This is the most direct way to resolve uncertainty but may not always be feasible or safe.
* *Blood Cultures:* If positive with the *same organism* found in the sputum, this is strong evidence of causality, as bacteremia often accompanies true VAP. However, sensitivity is low (~15% of VAP cases).
* *Molecular/PCR Panels:* Some institutions use multiplex PCR panels on BAL fluid. While they detect organisms, they often lack quantification and can be overly sensitive (detecting colonization). Their best use is for rapid detection of resistance genes (e.g., mecA, blaKPC) to guide therapy, not definitively prove causality.
#### C. Apply the "Principle of Parsimony" (Occam's Razor)
* Is the isolated organism the *simplest explanation* for the entire clinical syndrome? If a patient with new fever, purulent secretions, and a left lower lobe infiltrate grows Pseudomonas aeruginosa from their (admittedly suboptimal) sputum, and no other source of infection is found, then Pseudomonas VAP is the most parsimonious cause.
* Conversely, if the same patient has a clear alternative source (e.g., a C. diff positive diarrheal illness, a positive urine culture with a different organism), the sputum finding is more likely colonization.
#### D. Use the "Test of Therapy"
* This is a therapeutic diagnostic trial. It is *imperfect but pragmatic* and often the final arbiter in complex cases.
* *Initiate or narrow antibiotics* to cover the isolated organism.
* *Observe the clinical response:* Does the fever defervesce? Do oxygen requirements improve? Do white cell counts and procalcitonin normalize?
* *A clear positive response* strengthens the case for that organism being the causative pathogen.
* *Lack of response* forces you to reconsider: Is the organism resistant? (Check sensitivities again). Is there a co-pathogen? Is the primary issue not infectious (e.g., atelectasis, ARDS, pulmonary hemorrhage)?
### 3. Direct Link to Your Paper's Theme on Complexity
Your paper discusses navigating complexity in diagnosis and organizational systems. This VAP scenario is a perfect microcosm:
* *Clinical Complexity:* The diagnosis isn't a simple "if sputum culture positive, then VAP." It's a *syndromic diagnosis* where the microbiological data is one interconnected node in a network that includes clinical signs, radiologic nodes, biomarker nodes, and host factor nodes. The "few pus cells" report is an example of *ambiguous data* that the system (the clinician) must interpret within the larger context.
* *Organizational/Systemic Complexity:* The lack of a quantified sputum analysis reflects a *systemic constraint* (perhaps resource limitations, lab protocols, or training gaps). You, as the clinician, are operating at the interface of this imperfect system and the complex biological system of the patient. Your task is to "navigate in an optimized way," as your paper concludes, using the probabilistic framework above because a "simple" answer is unavailable.
### Practical Summary & Approach:
1. *Acknowledge the Limitation:* The current report is non-diagnostic by itself. It suggests, but does not prove, causality.
2. *Integrate All Data:* Weigh the microbiologic finding against the *clinical picture, biomarkers, and radiology.* Does it fit?
3. *Search for Corroborating Evidence:* Look for bacteremia, consider a better sample if possible.
4. *Apply the Test of Therapy:* Let the patient's response guide your belief about causality. A response to therapy targeted at the organism is strong, albeit retrospective, evidence.
5. *Document the Reasoning:* Given the complexity, clearly document your thought process: "Although sputum was not quantitatively validated, the isolation of X in the context of new fever, leukocytosis, and a right upper lobe infiltrate, with no other source found, makes VAP due to X the most likely diagnosis. Will treat accordingly and monitor response."
In essence, *organismal causality in VAP with imperfect data is established through a convergence of clinical plausibility, the absence of compelling alternative explanations, and ultimately, the patient's response to targeted therapy.* This is the art of navigating the complex system at the bedside.
[10.32 pm, 12/12/2025] PPM 1: 👏
[10:35 pm, 12/12/2025] PPM 5: Yes, Dr. Abdulsalam. Involuntary movements are a well-documented and common feature of Unresponsive Wakefulness Syndrome (UWS), formerly known as the Vegetative State.
For your medical students, it is crucial to clarify that these movements originate from brainstem or spinal reflexes rather than cortical, purposeful activity.
Here is a breakdown of the types of involuntary movements reported in UWS, which you can use to guide your students' observation:
1. Primitive & Brainstem Reflexes
These are the most common and are often preserved because the brainstem remains functional even when the cortex is severely damaged.
* Oral/Facial: Chewing, teeth grinding (bruxism), swallowing, yawning, and gagging.
* Ocular: Spontaneous eye-opening (the defining feature of "wakefulness"), slow roving eye movements, or "doll's eye" reflex.
* Teaching Point: If the patient exhibits sustained visual pursuit (tracking a moving object/person consistently) or fixation, this is often the first sign they have transitioned to a Minimally Conscious State (MCS), rather than UWS.
* Grasp Reflex: Automatic grasping when the palm is stimulated.
2. Motor Tone & Posturing
* Spasticity & Rigidity: High muscle tone is very common (reported in up to 89% of cases).
* Posturing: You may see decorticate (flexion of arms, extension of legs) or decerebrate (extension of arms and legs) posturing, often triggered by noxious stimuli (like suctioning or pain) or occurring spontaneously.
3. Myoclonus (Post-Hypoxic)
If the UWS was caused by hypoxia (e.g., cardiac arrest), the patient may exhibit myoclonus.
* These are sudden, brief, shock-like jerks of a muscle or group of muscles.
* This is sometimes referred to as Lance-Adams Syndrome if it becomes chronic. It can be mistaken for seizure activity or voluntary movement by inexperienced observers.
4. Spontaneous "Random" Movements
* Patients may moan, grunt, or smile/grimace.
* Limb movements may appear "thrashing" or restless but lack a specific goal (non-purposeful).
Summary for your students:
The key diagnostic challenge is determining purpose.
* UWS: Movements are reflexive, spontaneous, or triggered by stimuli but are not reproducible responses to command.
* MCS: Movements show localized or purposeful behavior (e.g., reaching for an object rather than just grasping what touches the hand, or smiling in response to a voice).
Would you like me to pull up the Coma Recovery Scale-Revised (CRS-R) criteria for differentiating these movements specifically?
[10.37 pm, 12/12/2025] PPM 1: 👏
[11:01 pm, 12/12/2025] PPM 11: How was ET cultures sent..?
Is patient spiking fever..?
Going by the fever chart first spike is after 3 days. Of fever possibility of VAP
Curious to know reason for Hyperosmolar hyponatremia at the time of admission with urea 80. Sugars..?
[11:21 pm, 12/12/2025] PPM 7: Part of Et tube was sent (which had to be replaced)
[11:22 pm, 12/12/2025] PPM 7: On presentation grbs:87 sir
[11:40 pm, 12/12/2025] PPM 11: Okay Good. Which part was sent and how was that part departed from the ET tube..?
Grbs 87, urea 80, Na 112, serum osmolarity 398..?
[12:28 am, 13/12/2025] PPM 7: The bulb was sent sir
[8:00 am, 13/12/2025] PPM 11: I assume the bulb was cut through routinely used scissors on nursing deck which is already contaminated with Acenitobacter. Why was BAL or miniBAL was not preferred ..?
Reason for Serum osmolarity with urea 80 ..?
Can you update current SOAP of patient.
[1:01 pm, 13/12/2025] PPM 7: Subjective:
Spontaneous eye opening present
Involuntarily movement of limbs
Fever spikes-2 episodes
?Decorticate rigidity
Oposthitonus(one day back)
Objective:Gcs:E4VTM4
Pupils:Mid dilated and reactive to light
Urea:151
Creat:3.1
Sodium:
Potassium:
Chloride:
Hb:8.6
Tlc:42,000
Plt:.4 lakhs
I/O:1300/1550 ml
PH:7.3
PCO2:24
PO2:101
Hco3:13.8
Spo2:100 % with 10 lit of oxygen
Ecg: hyperacute t waves in v2-v6(decreased in magnitude)
Assessment:
Altered sensorium secondary to hypoxic ischemic encephalopathy
Recurrent seizures with? post ictal state
Hyponatremia (hypertonic)
Sepsis with aki (focus of infection?) with MODS
Acute Pulmonary edema secondary to alcoholic induced? coronary vasculopathy
Aspiration pneumonia
S/p 5 sessions of hemodialysis done
S/p extubation day-2
Plan:
Inj.lasix 40 mg iv/bd
Inj.piptaz 2.25 gm iv/qid
inj.clindamycin 600 mg iv/tid
Inj.thiamine 200 mg iv/bd
Inj.levipil 1 gm iv/bd
Inj.sodium valproate 500 mg iv/bd
Inj.thiamine 400 mg iv/bd
Tab.ecospirin ab 75/20 mg rt/hs
Tab.metoprolol 25 mg rt/od
Tab.paracetamol 650 mg rt/tid
Nebs with budecort, mucomist
Rt feeds (milk and water)
Uncertainties:
Why hyponatremia?
Reason for further neurological deterioration
[1:02 pm, 13/12/2025] PPM 7: Yes it was cut with scissors
[1:02 pm, 13/12/2025] PPM 7: We don't know the cause for increased serum osmolarity
Continuous alcohol consumption leading to dehydration leading to increased serum osmolarity or recurrent seizures?
[1:21 pm, 13/12/2025] PPM 10: The CXR for this one definitely did seem more suggestive of pulmonary edema than consolidation from the start.
[1:26 pm, 13/12/2025] PPM 11: Thanks for sharing.
1. As a medical student I am curious to see that spontaneous eye opening despite of HIE could be a sign of recovering brain tissue.?
2. Interested to see image of opisthotonus..?
3. spiking fevers with involuntary movements with high TLC Interested in looking CSF for meningism/meningitis of any cause..?
4. Interested to see smear of 42000 of TLC to look for lukemoid reaction vs CML ( can cause lukemic infiltration of meninges)
5. rationale for keeping patient in net Negative balance (-200 and also ~700-1000ml of insensible loss = 900-1200 ml NET LOSS)
6. Significance of hyper acute T waves in precordial leads of this patient..?
7. what was is PCV / HCT to label him dehydrated. Contrary to our volume overload hypotheses of pulmonary edema and HF.
8. How was serum osmolarity calculated - by lab test or manual measurements using formula.?
[1:29 pm, 13/12/2025] PPM 10: Good questions, if it was lab measured and doesn't correlate with calculated osmolarity then we'll have to seek other causes. Otherwise raised BUN is probably contributing to elevated osmolarity.
[1:29 pm, 13/12/2025] PPM 11: Thanks.
In this case cultures sensitivity report of acinetobactot is questionable?
What barriers do we have to send for BAL or miniBAL..?
[1:31 pm, 13/12/2025] PPM 10: Which raises an interesting point i.e. classifying hyponatremia to identify cause in presence of a factor causing hyperosmolarity (usually hypotonic hyponatremia is worked up for "true" hyponatremia causes).
[1:35 pm, 13/12/2025] PPM 11: Calculated osm - 242
Creating a osmolar gap of 156.
So some thing big happened.
Could be error in measurement
Could be error in the drink.
An osmolar gap of 156 mOsm/kg is extremely elevated and indicates severe toxic alcohol ingestion. The amount of alcohol required depends on which specific alcohol was consumed.[sydpath +1]
Calculation by Alcohol Type
For ethanol, using the standard conversion factor of 3.7-4.6:[pubmed.ncbi.nlm.nih +1]
• Ethanol level = 156 × 3.7 = 577 mg/dL (lower estimate)
• Ethanol level = 156 × 4.6 = 718 mg/dL (upper estimate)
This represents a potentially lethal ethanol concentration, as levels above 400-500 mg/dL are associated with severe toxicity and respiratory depression.[healthcare.uiowa]
For methanol (molecular weight 32 g/mol), the osmolar contribution per mg/dL is higher due to lower molecular weight:[ncbi.nlm.nih]
• Methanol level = 156 × 3.2 = approximately 499 mg/dL
For ethylene glycol (molecular weight 62 g/mol):[ncbi.nlm.nih]
• Ethylene glycol level = 156 × 6.2 = approximately 967 mg/dL
For isopropanol (molecular weight 60 g/mol):
• Isopropanol level = 156 × 6.0 = approximately 936 mg/dL
Clinical Context
An osmolar gap above 50 mOsm/kg strongly suggests toxic alcohol poisoning. At 156 mOsm/kg, this indicates life-threatening ingestion requiring immediate treatment with fomepizole or hemodialysis, particularly for methanol or ethylene glycol where toxic metabolites cause severe acidosis and organ damage. The normal osmolar gap ranges from -10 to +10 mOsm/kg.[emcrit +1]
[1:36 pm, 13/12/2025] PPM 7: 1.Spontaneous eye opening was present before one day of extubation, and there is not further improvement in sensorium
2.Unfortunately didn't record the oposthitonus
3.Spiking fever happened after 3 days of admission , meanwhile seizures are from 5 years, increased frequency since 3 days
However meningitis still might be possible I guess
4.The tlc on presentation was not raised, if is serially increasing, again suggesting towards the hospital acquired
5.pulmonary edema
6.Thats a mystery of hyperacute t waves
After discussing with cardio sir
He told might be due rate induced
Could be ischemia related changes
7.Pcv on presentation:25.4
Will attach the serial investigation chart here
8.Serum osmolarity was from lab
[1:42 pm, 13/12/2025] PPM 7: At the presentation consumption of unknown substance
And adulteration of alcohol was a suspicion
Whose effect should have been resolved by the hemodialysis
The osmolarity however became normal
Clinical condition didn't improve much
[1:43 pm, 13/12/2025] PPM 10: Exactly if alcohol/any dialysable substance was the case it would have been resolved by now.
[2:11 pm, 13/12/2025] PPM 11: Okay..!! Can Sudden osmotic change from 398 to normal osm, leads to Acute ODS / CPM ..? Where minimal or no neurological recovery is anticipated.
[2:13 pm, 13/12/2025] PPM 7: Mri brain was done after that actually didn't show any changes
[2:20 pm, 13/12/2025] PPM 11: Thanks. Can you share video of MRI Brain. And when exactly MRI was done after acute lowering of osmolarity..?
[2:34 pm, 13/12/2025] PPM 8: In general for any patient with altered sensorium, plz check
1. Metabolites: Na/K/Ca/Sugars/Ammonia/urea
2. BP
3. Brain: CSF, MRI (adem/pres/autoimmune)
4. Toxins
[3:19 pm, 13/12/2025] PPM 7: I'll reshare if you can't access it
[3:38 pm, 13/12/2025] PPM 11: Thanks, kindly reshare. Also when was it done after first dialysis in this admission.
[3.40 pm, 13/12/2025] PPM 1: 👏
[4:03 pm, 13/12/2025] PPM 7: After admission first dailysis was done in the evening around 7, then the next day 12 pm mri brain was done
[4:13 pm, 13/12/2025] PPM 11: MRI is the most sensitive diagnostic imaging modality to detect myelinolysis. MRI typically is normal at the onset of symptoms and may not become positive for as long as 4 weeks after disease onset. Our patient presented with quadriparesis and an MRI-positive demyelinating lesion after approximately 2 weeks of sodium correction during his initial hospitalisation.
Similar patient case report
[4:20 pm, 13/12/2025] PPM 1: @PPM11 regarding 2 this video was uploaded by @PPM7 before you joined this group and archived here 👇
[4:21 pm, 13/12/2025] PPM 1: 👆You will also find it archived in the case report link in the description box here @PPM11 along with YouTube links to his deidentified MRI videos.
[4:35 pm, 13/12/2025] PPM 1: Everything is meticulously archived by @CR in the globally accessible case report link in the description box so that we don't have to keep resharing these locally and can retain it long after this patient and all his local artifacts wither from our biological and locally stored memories
[4:39 pm, 13/12/2025] PPM 1: Yes we were worried the way his sodium had been increased from 112 to 125 after a two hour dialysis session
[4:41 pm, 13/12/2025] PPM 1: Even after the toxic levels of alcohol causes cerebral neuronal injury?
@Meta AI @PPM5 can we dig deep into recovery or permanent cerebral damage patterns after toxic alcohol ingestion?
[4:41 pm, 13/12/2025] Meta AI: Final Answer: N/A
You're getting pretty deep into the topic of alcohol toxicity and its effects on the brain 😬. Let's break it down.
Alcohol toxicity can cause cerebral neuronal injury, leading to various cognitive and motor impairments. The extent of recovery or permanence of damage depends on several factors, including:
1. Severity of exposure: Higher doses and longer exposure times increase the risk of permanent damage.
2. Type of alcohol: Methanol and ethylene glycol are more toxic than ethanol.
3. Treatment timing: Prompt treatment, including dialysis, can improve outcomes.
4. Individual factors: Age, health status, and genetic predisposition influence susceptibility.
Recovery Patterns:
| Pattern | Description |
| --- | --- |
| Reversible | Mild exposure may lead to reversible damage, with recovery possible within weeks to months. |
| Partial Recovery | Moderate exposure may result in partial recovery, with some residual deficits. |
| Permanent Damage | Severe exposure can cause permanent damage, leading to chronic cognitive and motor impairments. |
Mechanisms of Damage:
1. Oxidative stress: Alcohol metabolism generates reactive oxygen species, causing cellular damage.
2. Inflammation: Activation of immune cells and release of pro-inflammatory cytokines contribute to tissue damage.
3. Disruption of cellular processes: Alcohol interferes with normal cellular function, leading to cell death.
Potential for Recovery:
- Neuroplasticity: The brain's ability to reorganize and adapt may contribute to recovery.
- Stem cell therapy: Research suggests potential benefits of stem cell therapy in promoting neural repair.
Now, considering the complexity of cerebral damage, would you like to explore specific aspects, such as:
A) Biomarkers for diagnosis and prognosis
B) Treatment options for methanol poisoning
C) Neuropsychological rehabilitation strategies
D) Other (please specify)
[4.44 pm, 13/12/2025] PPM 1: Overall handwritten graphical summary @PPM5
